EP4096659A4 - Inhibiteurs de srebp comprenant un noyau central de thiophène - Google Patents

Inhibiteurs de srebp comprenant un noyau central de thiophène Download PDF

Info

Publication number
EP4096659A4
EP4096659A4 EP21748420.3A EP21748420A EP4096659A4 EP 4096659 A4 EP4096659 A4 EP 4096659A4 EP 21748420 A EP21748420 A EP 21748420A EP 4096659 A4 EP4096659 A4 EP 4096659A4
Authority
EP
European Patent Office
Prior art keywords
thiophene
central ring
srebp
inhibitors
srebp inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21748420.3A
Other languages
German (de)
English (en)
Other versions
EP4096659A1 (fr
Inventor
Michael John Green
Barry Patrick Hart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Capulus Therapeutics LLC
Original Assignee
Capulus Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capulus Therapeutics LLC filed Critical Capulus Therapeutics LLC
Publication of EP4096659A1 publication Critical patent/EP4096659A1/fr
Publication of EP4096659A4 publication Critical patent/EP4096659A4/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP21748420.3A 2020-01-27 2021-01-26 Inhibiteurs de srebp comprenant un noyau central de thiophène Pending EP4096659A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062966358P 2020-01-27 2020-01-27
US202063056410P 2020-07-24 2020-07-24
PCT/US2021/015101 WO2021154735A1 (fr) 2020-01-27 2021-01-26 Inhibiteurs de srebp comprenant un noyau central de thiophène

Publications (2)

Publication Number Publication Date
EP4096659A1 EP4096659A1 (fr) 2022-12-07
EP4096659A4 true EP4096659A4 (fr) 2023-10-18

Family

ID=77079187

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21748420.3A Pending EP4096659A4 (fr) 2020-01-27 2021-01-26 Inhibiteurs de srebp comprenant un noyau central de thiophène

Country Status (2)

Country Link
EP (1) EP4096659A4 (fr)
WO (1) WO2021154735A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024089216A1 (fr) 2022-10-27 2024-05-02 Syngenta Crop Protection Ag Nouveaux composés hétéroaryl-carboxamides contenant du soufre

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015031710A1 (fr) * 2013-08-29 2015-03-05 Baylor College Of Medicine Compositions et procédés de traitement de troubles métaboliques et troubles associés au poids corporel
WO2017190086A1 (fr) * 2016-04-29 2017-11-02 Fgh Biotech, Inc. Composés de pyrazole di-substitués pour le traitement de maladies
WO2018049080A1 (fr) * 2016-09-07 2018-03-15 Fgh Biotech, Inc. Composés de pyrazole di-substitués pour le traitement de maladies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5461197B2 (ja) * 2007-02-02 2014-04-02 ベイラー カレッジ オブ メディスン 代謝障害を処置するための組成物および方法
JP2017506618A (ja) * 2013-08-28 2017-03-09 メディベイション テクノロジーズ， インコーポレイテッド 複素環式化合物および使用方法
JP2018507235A (ja) * 2015-03-04 2018-03-15 メディベイション テクノロジーズ エルエルシー ステロール調節エレメント結合タンパク質（ｓｒｅｂｐ）阻害剤
JP2018507234A (ja) * 2015-03-04 2018-03-15 メディベイション テクノロジーズ エルエルシー 肝臓線維症、コレステロールの上昇およびインスリン抵抗性を処置する際における使用のためのｓｒｅｂｐ遮断薬

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015031710A1 (fr) * 2013-08-29 2015-03-05 Baylor College Of Medicine Compositions et procédés de traitement de troubles métaboliques et troubles associés au poids corporel
WO2017190086A1 (fr) * 2016-04-29 2017-11-02 Fgh Biotech, Inc. Composés de pyrazole di-substitués pour le traitement de maladies
WO2018049080A1 (fr) * 2016-09-07 2018-03-15 Fgh Biotech, Inc. Composés de pyrazole di-substitués pour le traitement de maladies

Also Published As

Publication number Publication date
EP4096659A1 (fr) 2022-12-07
WO2021154735A1 (fr) 2021-08-05

Similar Documents

Publication Publication Date Title
EP3917513A4 (fr) Inhibiteurs de srebp comprenant un noyau central de tiophène
EP3746070A4 (fr) Inhibiteurs de srebp comprenant un noyau central à 6 chaînons
EP4061354A4 (fr) Dispositifs anneaux intravaginaux
EP4096659A4 (fr) Inhibiteurs de srebp comprenant un noyau central de thiophène
IL289314A (en) Consequence of transformed tetrahydroisoquinoline as a d1 positive allosteric modulator
EP4058014A4 (fr) Inhibiteurs de srebp comprenant un cycle central de tiophène
EP3830018A4 (fr) Support de cric robuste
EP4149367A4 (fr) Écouvillon
EP4146084A4 (fr) Écouvillon
EP4183122A4 (fr) Synchronisation d'une configuration de service partagée à travers des instances de calcul
EP4041206A4 (fr) Auxiliaire cannabinoïde à teneur réduite en terpène
EP3981187A4 (fr) Système de communication de capacité élevée innovant
IL289317A (en) Consequence of transformed tetrahydroisoquinoline as a positive d1 allosteric modulator
EP4149366A4 (fr) Écouvillon
EP4169519A4 (fr) Îlot encapsulé
AU2021902282A0 (en) A transportable hay distributor
AU2020904867A0 (en) A Magnetic Walking Aid
EP4209096A4 (fr) Nouvelle configuration de mesure
AU2019901479A0 (en) A portable kettle bell
AU2021901349A0 (en) A protective capsule
AU2019901737A0 (en) A plug
AU2023902908A0 (en) A Playboard
AU2023902631A0 (en) Nano-circuit Breaker - Type A
AU2021903364A0 (en) A loofah
AU2023903419A0 (en) A plug for a bath

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220802

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031442700

Ipc: C07D0409040000

A4 Supplementary search report drawn up and despatched

Effective date: 20230914

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/4436 20060101ALI20230908BHEP

Ipc: A61K 31/436 20060101ALI20230908BHEP

Ipc: A61P 3/06 20060101ALI20230908BHEP

Ipc: A61P 1/16 20060101ALI20230908BHEP

Ipc: C07D 491/056 20060101ALI20230908BHEP

Ipc: C07D 409/04 20060101AFI20230908BHEP